Stay updated on ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedThe study record for the ZEP-3Na atopic dermatitis trial is displayed in place of an error page, with details on the treatment, participants, trial sites, and measures of safety and efficacy.SummaryDifference60%

- Check10 days agoChange DetectedThe site revision identifier changes from v3.7.2 to v3.8.0; the page otherwise remains a 403 Forbidden error rather than showing the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision changes from v3.7.1 to v3.7.2. The page’s main content remains a 403 Forbidden error.SummaryDifference1%

- Check38 days agoChange DetectedThe 403 Forbidden page’s footer revision label changed from v3.7.0 to v3.7.1, while the study record remains unavailable.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error page instead of the study record details, including a DOCTYPE and a 403 message. This indicates the study record is currently inaccessible or access-restricted.SummaryDifference19%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0, signaling a new site build. The study details and visible content remain unchanged.SummaryDifference0.0%

Stay in the know with updates to ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZEP-3Na Safety & Efficacy in Atopic Dermatitis Clinical Trial page.